In cases where hepatitis (including hepatocellular, cholestatic or mixed liver injury) has been diagnosed, olanzapine treatment should be discontinued.
I tilfælde, hvor hepatitis (inklusiv hepatocellulær, cholestatisk eller blandet leverskade) er diagnosticeret, bør olanzapin seponeres.